Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!

Nasdaq Erases Post-FOMC-Minutes Plunge After (Another) Vaccine Headline

Courtesy of ZeroHedge View original post here.

Yield Curve Control, who needs it?!

And all it took was Johnson & Johnson reporting that they plan to launch, by late September, what could become the largest clinical trial of a coronavirus vaccine to date, enlisting up to 60,000 people world-wide to test whether its experimental shot safely protects from COVID-19.

The targeted enrollment, reported on a government database and confirmed by the company, is double the size of other pivotal studies that have started recently or are expected imminently for vaccines developed by Moderna Inc., Pfizer Inc. and AstraZeneca PLC.

And just like that, all those fears are gone.


Do you know someone who would benefit from this information? We can send your friend a strictly confidential, one-time email telling them about this information. Your privacy and your friend's privacy is your business... no spam! Click here and tell a friend!





You must be logged in to make a comment.
You can sign up for a membership or get a FREE Daily News membership or log in

Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!